| Literature DB >> 19440546 |
Kiran Yanamandra1, Oleg Alexeyev, Vladimir Zamotin, Vaibhav Srivastava, Andrei Shchukarev, Ann-Christin Brorsson, Gian Gaetano Tartaglia, Thomas Vogl, Rakez Kayed, Gunnar Wingsle, Jan Olsson, Christopher M Dobson, Anders Bergh, Fredrik Elgh, Ludmilla A Morozova-Roche.
Abstract
BACKGROUND: The conversion of solubleEntities:
Mesh:
Substances:
Year: 2009 PMID: 19440546 PMCID: PMC2678268 DOI: 10.1371/journal.pone.0005562
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Proteins identified in CA samples from the selected group of patients by liquid chromatography-electrospray ionization mass spectrometry.
| Protein | Accession number |
| Number of identified unique peptides ( | ||||||
| P1 | P2 | P3 | P4 | P5 | P6 | P7 | |||
| S100A8 | IPI00007047 | 10 | 2 (24) | 1 (11) | 1 (11) | 2 (24) | 2 (24) | 3 (31) | 3 (31) |
| S100A9 | IPI00027462 | 13 | 3 (36) | 2 (25) | 1 (13) | 1 (13) | 1 (13) | 4 (31) | 3 (26) |
| Human serum albumin | IPI00745872 | 67 | 10 (24) | 6 (14) | 24 (60) | 16 (38) | 13 (31) | # | 5 (10) |
| α-1-acid glycoprotein 1 | IPI00022429 | 21 | # | 1 (8) | 2 (13) | 2 (24) | 1 (8) | # | # |
| Zinc-α-2-glycoprotein | IPI00166729 | 32 | # | # | 3 (16) | 5 (21) | 3 (12) | # | # |
| Hemoglobin subunit α | IPI00410714 | 15 | 2 (14) | # | 1 (11) | # | # | 1 (11) | # |
| Hemoglobin subunit β | IPI00654755 | 16 | 1 (9) | # | # | # | # | # | # |
| Cathepsin G | IPI00028064 | 27 | 2 (9) | # | # | # | # | 3 (11) | # |
| Neutrophil defensin 1 | IPI00005721 | 8 | 1 (12) | # | # | # | # | # | # |
| Myeloperoxidase | IPI00007244 | 79 | 1 (2) | # | # | # | # | 12 (10) | # |
| Prostate-specific antigen | IPI00010858 | 27 | # | # | # | # | 1 (5) | # | # |
| Haptoglobin | IPI00431645 | 31 | # | # | 5 (25) | # | # | # | # |
Calculated after removing signal peptide from their precursor sequence. # No significant identification.
Escherichia coli (E. coli) proteins identified in CA samples by liquid chromatography-electrospray ionization mass spectrometry.
| Protein | Accession number | Organism | Protein size (kDa) |
| Co-chaperonin GroES | NP_290775 |
| 10 |
| Heat shock protein GrpE | NP_289166 |
| 22 |
| ATP-dependent protease regulatory subunit | CAA40846 |
| 66 |
A single peptide from each protein was identified.
Figure 1Immunoassays of CA proteinaceous components.
(A) Western blots of CA extracts from three representative specimens with S100A9, S100A8 and human serum albumin antibodies; the staining of aggregates in stacking gel with corresponding antibodies is shown in the right column. (B and C) Immunostaining of CA and surrounding tissues with S100A8 and S100A9 antibodies, respectively, shown in brown; the positive S100A8/A9-staining of CA (1), macrophages in stroma (2), macrophages in epithelium tissues (3) and the focal epithelial staining (4) are indicated by numbers and arrows. (D) Co-immunostaining of CA inclusions with anti-S100A8 (shown in purple) and anti-S100A9 antibodies (shown in brown). (E) Lack of CA immunostaining by human serum albumin antibodies (CA body does not display purple colour). (F and G) Immunostaining of the prostate CA inclusions by antibodies towards amyloid fibrils shown in purple with low and high magnification. The magnification is indicated in left lower corner of each image.
Figure 2AFM and TEM imaging of ex vivo and in vitro S100A8/A9 amyloid structures.
(A) AFM images of ex vivo amyloid oligomers, chain-like sequences are indicated by blue arrow; (B) ex vivo amyloid fibrillar network; (C,D) TEM images of ex vivo amyloid superstructures; (E) AFM images of S100A8/A9 oligomeric assemblies produced at pH 7.4, 37°C with agitation after 2 week of incubation, (F,G) fibrillar bundles produced at pH 7.4, 37°C with agitation after 8 weeks; (H–K) heterogeneous types of S100A8/A9 amyloids produced at pH 2.0 and 57°C after 4 weeks of incubation with residual content of Ca and Zn. S100A8/A9 amyloids produced at pH 2.0 and 57°C after 2 weeks of incubation in the presence of (L) 1 mg/ml powdered Ca3(PO4)2 and (M) 10 mM ZnCl2; (N) aggregates observed in the presence of 50 mM EDTA. AFM cross-section analysis of amyloid structures indicated by red lines in corresponding images (O from B; P from F and Q from I). Scale bars are shown in white and equal to 250 nm in all AFM images.
Figure 3Intrinsic aggregation propensity profiles.
(A) S100A8 and (B) S100A9 aggregation propensity profiles denoted at pH 7.0 by red, at pH 2.0 – by turquoise and in the natively folded S100A8/A9 complex – by blue lines, respectively. Calcium-binding sites are indicated by green, α-helices – by black and β-strands – by blue bars, respectively.
Figure 4Chemical content of CA inclusions.
(A) XPS survey and (B) FTIR spectra of powdered prostate CA material.
Figure 5X-ray powder diffraction patterns of CA inclusions.
(A) Hydroxylapatite − (Ca5(PO4)3OH) and (B) whitlockite − (Ca2(PO4)3) crystalline phases of CA.
Figure 6Inflammation-dependent pathways of the prostate CA formation.
Infection, inflammation and amyloid self-assembly of S100A8/A9 proteins in the presence of calcium or/and zinc are important factors leading to CA depositions in the prostate gland.